# Early-onset and Late-onset Sporadic Alzheimer's Disease (AD)

> **NCT00987090** · NA · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 240 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **BIOLOGICAL:** Clinic and neuropsychologic evaluation
- **RADIATION:** MRI
- **PROCEDURE:** PET
- **BIOLOGICAL:** Apolipoprotein E genotyping
- **BIOLOGICAL:** Study of cerebrospinal fluid

## Key facts

- **NCT ID:** NCT00987090
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** 2016-09
- **Final completion:** —
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2015-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00987090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00987090, "Early-onset and Late-onset Sporadic Alzheimer's Disease (AD)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00987090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*